These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 1322688)
1. In vivo and in vitro 31P magnetic resonance spectroscopy of focal hepatic malignancies. Cox IJ; Bell JD; Peden CJ; Iles RA; Foster CS; Watanapa P; Williamson RC NMR Biomed; 1992; 5(3):114-20. PubMed ID: 1322688 [TBL] [Abstract][Full Text] [Related]
2. EVALUATION OF ANTIVIRAL THERAPY TREATMENT FOR LIVER CIRRHOSIS CAUSED BY CHRONIC HEPATITIS C AND HEPATITIS C BY 31P-MRS, BASED ON METABOLITE DETECTION. Gu JS; Sun RR; Shen S; Yu ZJ J Biol Regul Homeost Agents; 2015; 29(2):443-50. PubMed ID: 26122235 [TBL] [Abstract][Full Text] [Related]
3. High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease. Jeon MJ; Lee Y; Ahn S; Lee C; Kim OH; Oh BC; Yu U; Kim H Acta Radiol; 2015 Sep; 56(9):1051-60. PubMed ID: 25270373 [TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts. Taylor-Robinson SD; Sargentoni J; Bell JD; Thomas EL; Marcus CD; Changani KK; Saeed N; Hodgson HJ; Davidson BR; Burroughs AK; Rolles K; Foster CS; Cox IJ Gut; 1998 May; 42(5):735-43. PubMed ID: 9659173 [TBL] [Abstract][Full Text] [Related]
5. Cirrhosis of the human liver: an in vitro 31P nuclear magnetic resonance study. Taylor-Robinson SD; Thomas EL; Sargentoni J; Marcus CD; Davidson BR; Bell JD Biochim Biophys Acta; 1995 Oct; 1272(2):113-8. PubMed ID: 7548234 [TBL] [Abstract][Full Text] [Related]
6. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques. Cox IJ; Menon DK; Sargentoni J; Bryant DJ; Collins AG; Coutts GA; Iles RA; Bell JD; Benjamin IS; Gilbey S J Hepatol; 1992 Mar; 14(2-3):265-75. PubMed ID: 1323598 [TBL] [Abstract][Full Text] [Related]
7. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study. Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051 [TBL] [Abstract][Full Text] [Related]
8. Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro. Thomas CP; Dixon RM; Tian M; Butler SA; Counsell CJ; Bradley JK; Adams GE; Radda GK Br J Cancer; 1994 Apr; 69(4):633-40. PubMed ID: 8142251 [TBL] [Abstract][Full Text] [Related]
9. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715 [TBL] [Abstract][Full Text] [Related]
10. In vivo Metabolic Profiles as Determined by Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683 [TBL] [Abstract][Full Text] [Related]
11. Visibility of phospholipids in 31P NMR spectra of human breast tumours in vivo. Lowry M; Porter DA; Twelves CJ; Heasley PE; Smith MA; Richards MA NMR Biomed; 1992; 5(1):37-42. PubMed ID: 1550708 [TBL] [Abstract][Full Text] [Related]
12. Chemical assessment of phospholipid and phosphoenergetic metabolites in regenerating rat liver measured by in vivo and in vitro 31P-NMR. Morikawa S; Inubushi T; Kitoh K; Kido C; Nozaki M Biochim Biophys Acta; 1992 Oct; 1117(3):251-7. PubMed ID: 1420275 [TBL] [Abstract][Full Text] [Related]
13. Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and in vitro. Bhujwalla ZM; Aboagye EO; Gillies RJ; Chacko VP; Mendola CE; Backer JM Magn Reson Med; 1999 May; 41(5):897-903. PubMed ID: 10332871 [TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study. Abrigo JM; Shen J; Wong VW; Yeung DK; Wong GL; Chim AM; Chan AW; Choi PC; Chan FK; Chan HL; Chu WC J Hepatol; 2014 Apr; 60(4):809-15. PubMed ID: 24291241 [TBL] [Abstract][Full Text] [Related]
15. Phosphorus magnetic resonance spectroscopy in malformations of cortical development. Andrade CS; Otaduy MC; Valente KD; Maia DF; Park EJ; Valério RM; Tsunemi MH; Leite CC Epilepsia; 2011 Dec; 52(12):2276-84. PubMed ID: 21973076 [TBL] [Abstract][Full Text] [Related]
16. Tissue characterization and assessment of preoperative chemotherapeutic response in musculoskeletal tumors by in vivo 31P magnetic resonance spectroscopy. Redmond OM; Bell E; Stack JP; Dervan PA; Carney DN; Hurson B; Ennis JT Magn Reson Med; 1992 Oct; 27(2):226-37. PubMed ID: 1461110 [TBL] [Abstract][Full Text] [Related]
17. A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver. Bell JD; Cox IJ; Sargentoni J; Peden CJ; Menon DK; Foster CS; Watanapa P; Iles RA; Urenjak J Biochim Biophys Acta; 1993 Nov; 1225(1):71-7. PubMed ID: 8241291 [TBL] [Abstract][Full Text] [Related]
18. Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy. Schlemmer HP; Sawatzki T; Sammet S; Dornacher I; Bachert P; van Kaick G; Waldherr R; Seitz HK J Hepatol; 2005 May; 42(5):752-9. PubMed ID: 15826726 [TBL] [Abstract][Full Text] [Related]